| 000 | 01608pam a2200505 i 4500 | ||
|---|---|---|---|
| 999 |
_c25177 _d25177 |
||
| 001 | 2017029515 | ||
| 003 | DLC | ||
| 005 | 20190502000249.0 | ||
| 008 | 170620s2017 nyua b 001 0 eng | ||
| 010 | _a 2017029515 | ||
| 020 | _a9780735216204 | ||
| 020 | _a0735216207 | ||
| 040 |
_aDNLM/DLC _cDLC _erda _dGCmBT |
||
| 042 | _apcc | ||
| 050 | 1 | 4 |
_aRC523.2 _b.B735 2017 |
| 060 | 1 | 0 | _aWT 155 |
| 082 | 0 | 0 |
_a616.8/311 _223 |
| 091 | _a616.8311 | ||
| 100 | 1 |
_aBredesen, Dale E, _eauthor. _93380 |
|
| 245 | 1 | 4 |
_aThe end of Alzheimer's : _bthe first program to prevent and reverse cognitive decline / _cDale E. Bredesen, MD. |
| 264 | 1 |
_aNew York : _bAvery, an imprint of Penguin Random House, _c[2017] |
|
| 300 |
_a308 pages : _billustrations ; _c24 cm. |
||
| 336 |
_atext _2rdacontent. |
||
| 337 |
_aunmediated _2rdamedia. |
||
| 338 |
_avolume _2rdacarrier. |
||
| 504 | _aIncludes bibliographical references (pages 295-298) and index. | ||
| 650 | 0 |
_aAlzheimer's disease _xTreatment. _93381 |
|
| 650 | 0 |
_aAlzheimer's disease _xPrevention. _93382 |
|
| 650 | 1 | 2 |
_aAlzheimer Disease _xtherapy. _93383 |
| 650 | 2 | 2 |
_aAlzheimer Disease _xpsychology. _93384 |
| 650 | 2 | 2 |
_aCognitive Dysfunction _xprevention & control. _93385 |
| 650 | 2 | 2 |
_aCognition _xphysiology. _93386 |
| 901 | _aLEASED170918B | ||
| 901 | _aLEASED170821B | ||
| 901 | _aLEASED170818D | ||
| 901 | _aLEASED170818C | ||
| 901 | _aLEASED170818B | ||
| 901 | _aLEASED170818A | ||
| 901 | _aLEASED170817D | ||
| 901 | _aLEASED170817C | ||
| 901 | _aLEASED170817B | ||
| 901 | _aLEASED170817A | ||
| 908 | 1 | 4 | _aRC523.2 |
| 942 |
_2ddc _cBOOK |
||